General Western Blot Reagents
Abcam trans-11-Methyl octadecenoate, 100MG
MW 296.5 Da, Purity >99%. Methyl ester of *trans*-11-octadecenoic acid. Possible insulinotropic effects. Use in lipid studies and as internal standard. See *trans*-11-octadecenoic acid (ab143923).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Oligomycin A, ATP synthase inhibitor, 5MG
MW 791.1 Da, Purity >97%. Macrolide antibiotic. ATP synthase inhibitor. Blocks the proton channel (Fo subunit) to uncouple oxidative phosphorylation. Shows antitumor activity. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Collagen III peptide, 1MG
Human Collagen III peptide is a Synthetic blocking peptide. >70% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: Collagen alpha-1(III) chain, COL3A1
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam ML-9, protein kinase inhibitor, 10MG
MW 361.3 Da, Purity >98%. Broad spectrum ATP-competitive protein kinase inhibitor (Ki values are 32, 4, and 54 μM for PKA, MLCK, and PKC respectively). Ca²+ channel blocker. Shows vasorelaxant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bisindolylmaleimide x I hydrochloride, PKC inhibitor, 5MG
MW 489 Da, Purity >98%. Selective, cell-permeable protein kinase C (PKC) inhibitor that displays 10-fold greater selectivity for PKCα (IC₅₀ = 9 nM) and 4-fold greater selectivity for PKCβI (IC₅₀ = 28 nM) over Ca²+-independent PKCε (IC₅₀ = 108 nM). Enhances cardiac contractility and protection from heart failure. Prevents T-cell activation and proliferation (IC₅₀s ranging from 30-150 nM) associated with chronic inflammatory responses in vivo. Also inhibits GRK2, GRK5, and GRK6 (IC₅₀ values are 29, 3.6, and 16 μM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clindamycin, inhibits protein synthesis, 10MG
MW 425 Da, Purity >99%. Broad spectrum antimicrobial agent. Active against Gram-positive and Gram-negative bacteria and selected protozoa. Competitive inhibitor of peptide formation in large 50S ribosomal unit. Orally active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anti Histone H3 Citrulline R2 AB283863-1MG
Anti Histone H3 Citrulline R2 AB283863-1MG
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anti Histone H3 Citrulline R2 AB283863-100UG
Anti Histone H3 Citrulline R2 AB283863-100UG
The product is subject to the following: Abcam Restricted Use Statement
American Research Products Inc Mouse Cytochrome P450 2E1 CYP
Mouse Cytochrome P450 2E1 (CYP2E1) ELISA kit from CUSABIO Detection Range 39 pg/mL-2500 pg/mL Sensitivity 9 75 pg/mL Sample serum plasma tissue homogenates cell lysates Method Sandwich
Abcam E. coli Positive Control (Escherichia coli ) Whole Cell Lysate - expressing 6X His tag protein
E. coli Positive Control (Escherichia coli ) Whole Cell Lysate - expressing 6X His tag protein
The product is subject to the following: Abcam Restricted Use Statement
Abcam Methyl tetracosanoate, Fatty acid methyl ester, 100MG
MW 382.7 Da, Purity >99%. Fatty acid methyl ester. Antidiabetic activity. Active in vitro. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PBFI AM, fluorescent K+ binding probe, 1MG
MW 1171.1 Da, Purity >94%. Cell-permeable, fluorescent K+ binding probe (Kd = 5 mM). Active *in vitro*. Non-specific esterases hydrolyze the AM esters to produce the water-soluble form of PBFI.Excitation is 340/390 nm.
The product is subject to the following: Abcam Restricted Use Statement